Citation Impact
Citing Papers
Clinical Pharmacokinetics of the Newer ACE Inhibitors
1990
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
1999
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Non-Transgenic Mouse Models of Kidney Disease
2016 Standout
Vascularized and functional human liver from an iPSC-derived organ bud transplant
2013 StandoutNature
Assessment of Chimeric Mice with Humanized Liver as a Tool for Predicting Circulating Human Metabolites
2010
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II
1990
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
Radioimmunoassay for immunoreactive [des-Leu10]-angiotensin I
1989
Multiple roles of adrenomedullin revealed by animal models
2002 StandoutNobel
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Mice with Cardiac-Restricted Angiotensin-Converting Enzyme (ACE) Have Atrial Enlargement, Cardiac Arrhythmia, and Sudden Death
2004 StandoutNobel
Clinical Pharmacokinetic Properties of the Macrolide Antibiotics
1989
Clinical Pharmacokinetic Properties of the Macrolide Antibiotics
1989
Blood Pressure, Cardiac, and Renal Responses to Salt and Deoxycorticosterone Acetate in Mice
2002
Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure
2003
The CYP2D6 Humanized Mouse: Effect of the Human CYP2D6 Transgene and HNF4 on the Disposition of Debrisoquine in the Mouse
2001
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Hemodynamic, Hormonal, and Renal Effects of Short-Term Adrenomedullin Infusion in Healthy Volunteers1
2000
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model
2015 StandoutNobel
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
2000 Standout
Blood Pressure–Independent Cardiac Hypertrophy Induced by Locally Activated Renin-Angiotensin System
1998
Why hypertensive patients vary in their response to oral debrisoquine.
1977
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid Arthritis
2008
Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo
2007 StandoutNobel
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement
2009
Cellular Uptake and Efflux of Azithromycin, Erythromycin, Clarithromycin, Telithromycin, and Cethromycin
2005
Aliskiren Reduces Blood Pressure and Suppresses Plasma Renin Activity in Combination With a Thiazide Diuretic, an Angiotensin-Converting Enzyme Inhibitor, or an Angiotensin Receptor Blocker
2006
POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
1977 Standout
Works of AN Brown being referenced
Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects
1982
A pharmacokinetic study of cilazapril in elderly and young volunteers.
1989
The pharmacokinetics and bioavailability of cilazapril in normal man.
1989
Pharmacokinetics of the Converting Enzyme Inhibitor Cilazapril in Normal Volunteers and the Relationship to Enzyme Inhibition: Development of a Mathematical Model
1987
Metabolism of Debrisoquine Sulphate in Rat, Dog and Man
1976
The pharmacokinetics and dose proportionality of cilazapril.
1989
The influence of food on the pharmacokinetics and ACE inhibition of cilazapril.
1989
Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
1987
Repeated Administration of the Converting Enzyme Inhibitor Cilazapril to Normal Volunteers
1987
A pharmacokinetic study of cilazapril in patients with congestive heart failure.
1989